• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿可溶性髓系细胞触发受体-1,肾脏病和炎症性疾病的一个新兴生物标志物。

SuPAR, an emerging biomarker in kidney and inflammatory diseases.

机构信息

Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

出版信息

Postgrad Med J. 2018 Sep;94(1115):517-524. doi: 10.1136/postgradmedj-2018-135839. Epub 2018 Sep 3.

DOI:10.1136/postgradmedj-2018-135839
PMID:30177549
Abstract

Soluble urokinase plasminogen activator receptor (suPAR) is a circulating form of a physiological and pathophysiological important cell surface receptor, implicated in inflammation. Recent studies showed that suPAR is a promising biomarker, useful for diagnosis, assessment and prognosis of several diseases. This review summarises the majority of preliminary studies and analyses the significance and the clinical application of suPAR in various clinical conditions. SuPAR seems to have a significant value in the diagnosis as well as prognosis of many diseases; nonetheless, it merits large-scale studies to set cut-off values that help physicians in following up their patients and accordingly tailor their treatment plans.

摘要

可溶性尿激酶型纤溶酶原激活物受体(suPAR)是一种循环形式的生理和病理生理学上重要的细胞表面受体,与炎症有关。最近的研究表明,suPAR 是一种很有前途的生物标志物,可用于多种疾病的诊断、评估和预后。本综述总结了大多数初步研究,并分析了 suPAR 在各种临床情况下的意义和临床应用。suPAR 在许多疾病的诊断和预后中似乎具有重要价值;然而,需要进行大规模的研究来确定有助于医生跟踪患者并相应地调整治疗计划的截断值。

相似文献

1
SuPAR, an emerging biomarker in kidney and inflammatory diseases.尿可溶性髓系细胞触发受体-1,肾脏病和炎症性疾病的一个新兴生物标志物。
Postgrad Med J. 2018 Sep;94(1115):517-524. doi: 10.1136/postgradmedj-2018-135839. Epub 2018 Sep 3.
2
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为全身性慢性炎症的生物标志物。
Front Immunol. 2021 Dec 2;12:780641. doi: 10.3389/fimmu.2021.780641. eCollection 2021.
3
suPAR: A New Biomarker for Cardiovascular Disease?可溶性尿激酶型纤溶酶原激活物受体:心血管疾病的新型生物标志物?
Can J Cardiol. 2015 Oct;31(10):1293-302. doi: 10.1016/j.cjca.2015.03.023. Epub 2015 Mar 25.
4
Soluble urokinase plasminogen activator receptor level in individuals of advanced age.高龄个体中可溶性尿激酶型纤溶酶原激活物受体水平。
Sci Rep. 2020 Sep 22;10(1):15462. doi: 10.1038/s41598-020-72377-w.
5
Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy.尿激酶型纤溶酶原激活物受体及其可溶性形式在常见活检证实的肾脏疾病和糖尿病肾病分期中的作用
Clin Biochem. 2015 Dec;48(18):1324-9. doi: 10.1016/j.clinbiochem.2015.07.001. Epub 2015 Jul 8.
6
Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.可溶性尿激酶型纤溶酶原激活物受体与更高的风险、更严重的疾病严重程度以及炎症有关,可能是重症急性胰腺炎的预后生物标志物。
J Clin Lab Anal. 2020 Mar;34(3):e23097. doi: 10.1002/jcla.23097. Epub 2019 Nov 27.
7
Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.循环可溶性尿激酶型纤溶酶原激活物在慢性肝病患者中升高,可区分肝硬化的分期和病因,并预测预后。
Liver Int. 2012 Mar;32(3):500-9. doi: 10.1111/j.1478-3231.2011.02665.x. Epub 2011 Oct 17.
8
Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?可溶性尿激酶型纤溶酶原激活物受体——系统性红斑狼疮中一种有价值的生物标志物?
Clin Chim Acta. 2015 Apr 15;444:234-41. doi: 10.1016/j.cca.2015.02.031. Epub 2015 Feb 19.
9
Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia.男性精神分裂症急性加重期患者血清可溶性尿激酶型纤溶酶原激活物受体水平。
Psychiatry Res. 2016 Feb 28;236:179-181. doi: 10.1016/j.psychres.2016.01.018. Epub 2016 Jan 9.
10
High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma.基线水平高的可溶性尿激酶型纤溶酶原激活物受体 (suPAR) 血清水平表明胰腺腺癌切除术后预后不良。
Carcinogenesis. 2019 Aug 22;40(8):947-955. doi: 10.1093/carcin/bgz033.

引用本文的文献

1
Advances in the diagnosis of early biomarkers for acute kidney injury: a literature review.急性肾损伤早期生物标志物诊断的研究进展:文献综述
BMC Nephrol. 2025 Mar 5;26(1):115. doi: 10.1186/s12882-025-04040-3.
2
Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study.可溶性尿激酶型纤溶酶原激活物受体(suPAR)在肥胖或 1 型糖尿病儿童中作为血管内皮功能障碍的标志物:一项横断面研究。
Eur J Pediatr. 2024 May;183(5):2383-2389. doi: 10.1007/s00431-024-05496-5. Epub 2024 Mar 7.
3
Novel inflammatory biomarkers in the prognosis of COVID-19.
新型炎症生物标志物在 COVID-19 预后中的作用。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231199679. doi: 10.1177/17534666231199679.
4
Can serum soluble urokinase plasminogen activator receptor be an effective biomarker in comparing the inflammatory response between laparoscopic and open appendectomy?血清可溶性尿激酶型纤溶酶原激活物受体能否作为比较腹腔镜阑尾切除术和开腹阑尾切除术炎症反应的有效生物标志物?
Wideochir Inne Tech Maloinwazyjne. 2023 Jun;18(2):351-357. doi: 10.5114/wiitm.2023.128681. Epub 2023 Jun 15.
5
Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review.当前系统性硬化症的血管生物标志物研究趋势:一项叙述性综述。
Int J Mol Sci. 2023 Feb 17;24(4):4097. doi: 10.3390/ijms24044097.
6
Kinetics of SuPAR hemoadsorption in critical COVID-19 patients on renal replacement therapy.严重 COVID-19 患者肾替代治疗时可溶性尿激酶型纤溶酶原激活物受体的血液吸附动力学。
BMC Nephrol. 2022 Nov 18;23(1):371. doi: 10.1186/s12882-022-03003-2.
7
The Perspective of Vitamin D on suPAR-Related AKI in COVID-19.维生素 D 对 COVID-19 中 suPAR 相关 AKI 的作用视角。
Int J Mol Sci. 2022 Sep 14;23(18):10725. doi: 10.3390/ijms231810725.
8
Air pollution and biomarkers of cardiovascular disease and inflammation in the Malmö Diet and Cancer cohort.空气污染与心血管疾病和炎症生物标志物在马尔默饮食与癌症队列中的研究
Environ Health. 2022 Apr 12;21(1):39. doi: 10.1186/s12940-022-00851-1.
9
Crystal structure and cellular functions of uPAR dimer.uPAR 二聚体的晶体结构和细胞功能。
Nat Commun. 2022 Mar 29;13(1):1665. doi: 10.1038/s41467-022-29344-y.
10
Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients.可溶性尿激酶型纤溶酶原激活物受体水平可预测 Afro-Caribbean 患者 COVID-19 的严重程度。
Biomark Med. 2022 Feb;16(3):169-177. doi: 10.2217/bmm-2021-0669. Epub 2022 Jan 27.